RT Journal Article
SR Electronic
T1 Differential risk for COVID-19 in the first wave of the disease (February-April 2020) among migrants from several areas of the world living in Alcorcón (Spain): A population-based cohort study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.25.20112185
DO 10.1101/2020.05.25.20112185
A1 Guijarro, Carlos
A1 Pérez-Fernández, Elia
A1 González-Piñeiro, Beatriz
A1 Meléndez, Victoria
A1 Goyanes, Maria José
A1 Renilla, Ma Esther
A1 Casas, Maria Luisa
A1 Sastre, Isabel
A1 Velasco, María
A1 ,
YR 2020
UL http://medrxiv.org/content/early/2020/09/03/2020.05.25.20112185.abstract
AB Little is known regarding the relevance of racial / ethnic background on the risk of COVID-IO infection, particularly in Europe. We evaluated the risk for COVID-19 among migrants from different areas of the world within a context of universal free access to medical care. We conducted a population-based cohort analysis of the cumulative incidence of PCR-confirmed COVID-19 among adult residents at Alcorcón (Spain) in the first wave of the disease. The crude cumulative incidence among migrants (n=20419) was higher than among Spaniards (n=131599): 8.81 and 6.51 and per 1000 inhabitants respectively (p<0.001) but differed by world region of origin. By negative binomial regression, adjusted for age and sex, relative risks (RR) for COVID-19 were not significantly different from Spaniards for individuals from Europe, Asia or Northern Africa. In contrast, there was a marked increased risk for Sub-Saharan Africa (RR 3.66, 95% confidence interval (Cl) 42-9.41, p=0.007), Caribbean (RR6.35, 95% Cl 3.83-10.55, p<0.001) and Latin-America (RR6.92, 95% Cl 4.49-10.67, p <0.001). Migrants from these areas of the world may deserve a closer attention both for clinical and epidemiological reasons.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding was available for this manuscriptAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB Hospital Universitario Fundacion AlcorconAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo individual patient data are avaiulable